Skip to main content
Premium Trial:

Request an Annual Quote

GE Reports Increased Revenues, Earnings in Q2; Healthcare Revenues Soar After Amersham Acquisition

NEW YORK, July 9 (GenomeWeb News) - General Electric reported its second quarter earnings today, which included results from recently acquired Amersham.


Total revenues for the quarter were $37 billion, up from $33.4 billion during the same period last year. GE Healthcare, which includes former Amersham, generated $3.4 billion in revenues, compared to $2.4 billion during the same quarter a year ago, prior to the Amersham acquisition.


GE did not break out Amersham's contribution to its Healthcare unit revenues, but Amersham had ₤427 million ($795 million) in sales during the second quarter of 2003.


The company's profits increased to $3.9 billion, up from $3.8 billion during the same quarter last year. GE Healthcare accounted for $584 million in profits, up from $440 million during the year-ago period.


As of the end of June, GE had $133.1 billion in cash and marketable securities.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.